Through important chemistry and the right engineering, there’s new opportunity for CAR T therapeutics to target different forms of cancer with limited toxicity.
- COGs And Biology, Two Endpoints Needlessly At Odds In Advanced Therapy
- The Long Road To U.S. Vaccine Manufacturing
- Compliance, Costs, And Site Readiness In CAR-T Clinical Trials
- All The Ways Global Biopharma Still Grapples With Annex 1
- Managing Operational Challenges In CAR-T Clinical Trial Logistics
- FDA's 483 Playbook: What It Means For Pharma Outsourcing — And What It Doesn't Address
- Organic Impurities: New Draft ICH Q3E Guidance For Leachables And Extractables
- Building Harmonized Real‑World Data In Oncology
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1088537588 disease]( "EMA Support For Rare Disease Therapies")
EMA Support For Rare Disease TherapiesReview how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
![GettyImages-2157709064]( "Key Takeaways And Market Insights From The Inaugural ThinkLive Summit")
Key Takeaways And Market Insights From The Inaugural ThinkLive SummitThe inaugural ThinkLive Cell and Gene Therapy Summit explored the industry’s dynamic landscape, highlighting collaboration, communication, and market access challenges.
-
![Funnel]( "How Ergonomics And Cleaning Ease Reduce Repetitive Stress Injuries And Contamination In Pharmaceutical Lab Workflows")
How Ergonomics And Cleaning Ease Reduce Repetitive Stress Injuries And Contamination In Pharmaceutical Lab WorkflowsThe repetitive nature of routine laboratory procedures can put technicians and scientists at risk for repetitive strain injury. Routine activities often include reoccurrence of the same movements over and over, which can take a toll on hands, wrists and shoulders and ultimately can lead to serious damage. Choosing the right tools can make all the difference.
-
![Esco downflow booth]( "Raise Your Standards With Downflow Booth Airflow Containment")
Raise Your Standards With Downflow Booth Airflow ContainmentEnsure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.
-
![GettyImages-597971944-viral-vector-AAV-adeno-associated-virus]( "The Key To Viral Vector Success")
The Key To Viral Vector SuccessEstablishing a robust and scalable viral vector process requires a multidisciplinary approach that incorporates expertise in foundational science, analytics, and biomanufacturing.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Enhancing Novel Developability Through Automated MS Analytics")
Enhancing Novel Developability Through Automated MS AnalyticsGrowing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.
-
![Lipid nanoparticle mRNA vaccine-GettyImages-1418152448]( "Development Of LNP Formulations Using The KNAUER NanoScaler")
Development Of LNP Formulations Using The KNAUER NanoScalerLipid nanoparticles (LNPs) offer a robust solution for nucleic acids. The NanoScaler system optimizes this technology, enabling scalable and reproducible LNP formulations for diverse applications.
-
![GettyImages-1327318287-spheres-cancer-cells-microscopic]( "Cell Culture Automation Of The 3D Cancer Spheroid Assay")
Cell Culture Automation Of The 3D Cancer Spheroid AssayDiscover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.
-
![GettyImages-1409578453-mRNA-LNP-lipid-nanoparticle-RNA therapy]( "TFF Cassettes With 100 kDa Membranes For RNA And LNP Applications")
TFF Cassettes With 100 kDa Membranes For RNA And LNP ApplicationsThis study showcases the performance of regenerated cellulose flat sheet membranes with a 100 kDa molecular weight cutoff for UF/DF of RNA molecules by TFF.
-
![scientist experimented in laboratory-GettyImages-909089478]( "Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing")
Comprehensive Pathway To Seamless Scale-Up Of mRNA DP ManufacturingAn integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.
NEWSLETTER ARCHIVE
- 03.20.26 -- Lessons From Bringing A New T Cell Class For Autoimmune Diseases To Clinic
- 03.19.26 -- Your Guide To AAV Success: Characterization, QC, And Viral Clearance Strategies
- 03.19.26 -- Powering AI And Synthetic Biology In Therapy Design
- 03.18.26 -- Advance Your MSC Process: New Research, Expert Talks, And Scaling Solutions
- 03.18.26 -- Proteomics Tools: A Resurrection
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
